Linaclotide in constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: a profile of its use in the USA Kate McKeageKatherine A. Lyseng-Williamson Adis Drug Q&A 27 September 2017 Pages: 497 - 504
Decitabine in newly diagnosed acute myeloid leukaemia: a profile of its use in the EU Kate McKeageKatherine A. Lyseng-Williamson Adis Drug Q&A 23 September 2017 Pages: 505 - 514
Certolizumab pegol administration devices: a profile of their use and usability Katherine A. Lyseng-Williamson Adis Drug Q&A 03 October 2017 Pages: 515 - 522
Treat γ-hydroxybutyrate (GHB) and γ-butyrolactone (GBL) dependence with benzodiazepines first, then with other approaches if benzodiazepine-resistant Adis Medical Writers Disease Management 13 September 2017 Pages: 523 - 528
Manage psychiatric symptoms in Cushing’s syndrome by controlling cortisol levels and usual psychiatric therapy Adis Medical Writers Disease Management 15 September 2017 Pages: 529 - 534
Treat secondary hyperparathyroidism in chronic kidney disease according to disease severity and trends in laboratory markers Adis Medical Writers Disease Management 13 September 2017 Pages: 535 - 540
First reports of adverse drug reactions Drug Reactions and Interactions 03 October 2017 Pages: 541 - 542
Assessment of inappropriate medication use in elderly inpatients of a tertiary care hospital in south-eastern India using the modified updated Beers criteria 2003 Pradeep DevarapalliSeema SoniSudhakar Babu A.M.S Original Research Article 20 September 2017 Pages: 543 - 549